日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

LTBK-04. 溶瘤腺病毒 DNX-2401 (TASADENOTUREV) 联合帕博利珠单抗治疗复发性胶质母细胞瘤的 II 期多中心研究;封闭式研究 (KEYNOTE-192)

Niu, Xiaodong; Yang, Yuan; Zhou, Xingwang; Zhang, Haodongfang; Zhang, Yuekang; Liu, Yanhui; Mao, Qing; Soffietti, Riccardo; Viapiano, Mariano; Hegi, Monika; Ghosh, Sourav; Purow, Benjamin; Reardon, David A; Brem, Steven; Desai, Arati Suvas; Bagley, Stephen Joseph; Kurz, Sylvia Christine; De La Fuente, Macarena Ines; Nagpal, Seema; Welch, Mary Roberta; Hormigo, Adilia; Forsyth, Peter; Mandell, Jacob; Khagi, Simon; Aiken, Robert; Walbert, Tobias; Lieberman, Frank; Portnow, Jana; Batiste, James; Carroll, Nicholas; Sylvester, Albert; Campbell, Patricia; Lowy, Israel; Dolgoter, Alex; Boyer, Jean; Kraynyak, Kimberly; Morrow, Matthew P; McMullan, Trevor; Weiner, David B; Skolnik, Jeffrey; Zadeh, Gelareh; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim; Nair, Suresh G; Puduvalli, Vinay K; Nassiri, Farshad; Sonabend, Adam M; Agensky, Laura; Ewald, Brett; Levisetti, Matteo; Lang, Frederick F

Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes

基于模型的PF-06342674(一种针对IL-7受体α的人源化单克隆抗体)在1型糖尿病成人患者中的药代动力学、靶点结合生物标志物和免疫调节活性表征

Williams, Jason H; Udata, Chandrasekhar; Ganguly, Bishu J; Bucktrout, Samantha L; Joh, Tenshang; Shannon, Megan; Wong, Gilbert Y; Levisetti, Matteo; Garzone, Pamela D; Meng, Xu

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes

人源化抗IL-7R单克隆抗体RN168在1型糖尿病患者中的免疫调节活性

Herold, Kevan C; Bucktrout, Samantha L; Wang, Xiao; Bode, Bruce W; Gitelman, Stephen E; Gottlieb, Peter A; Hughes, Jing; Joh, Tenshang; McGill, Janet B; Pettus, Jeremy H; Potluri, Shobha; Schatz, Desmond; Shannon, Megan; Udata, Chandrasekhar; Wong, Gilbert; Levisetti, Matteo; Ganguly, Bishu J; Garzone, Pamela D

Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease

博舒替尼与安慰剂治疗常染色体显性多囊肾病

Tesar, Vladimir; Ciechanowski, Kazimierz; Pei, York; Barash, Irina; Shannon, Megan; Li, Ray; Williams, Jason H; Levisetti, Matteo; Arkin, Steven; Serra, Andreas

A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin Therapy

一项针对接受他汀类药物治疗的高胆固醇血症患者的I期随机研究,评估一种专门设计的pH敏感型PCSK9抑制剂RN317(PF-05335810)的疗效。

Levisetti, M; Joh, T; Wan, H; Liang, H; Forgues, P; Gumbiner, B; Garzone, P D

Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?

致糖尿病 II 类分子的肽结合特性能否解释自身反应性?

Suri, Anish; Levisetti, Matteo G; Unanue, Emil R

Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy

非肥胖糖尿病小鼠迅速发展为严重的交感神经营养不良:一种新的糖尿病自主神经病变实验模型

Schmidt, Robert E; Dorsey, Denise A; Beaudet, Lucie N; Frederick, Kathy E; Parvin, Curtis A; Plurad, Santiago B; Levisetti, Matteo G

Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice

肝细胞核因子1α缺陷小鼠的胰岛素分泌存在缺陷

Pontoglio, M; Sreenan, S; Roe, M; Pugh, W; Ostrega, D; Doyen, A; Pick, A J; Baldwin, A; Velho, G; Froguel, P; Levisetti, M; Bonner-Weir, S; Bell, G I; Yaniv, M; Polonsky, K S